VYGR vs. FMED
VYGR (Voyager Therapeutics, Inc.) is a stock, while FMED (Fidelity Disruptive Medicine ETF) is Health & Biotech Equities fund actively managed by Fidelity. Over the past 3 years, VYGR returned -31.60%/yr vs 4.71%/yr for FMED. At a 0.50 correlation, their price movements are largely independent.
Performance
VYGR vs. FMED - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VYGR achieves a -22.65% return, which is significantly lower than FMED's 6.51% return.
VYGR
- 1D
- -5.00%
- 1M
- -13.88%
- 6M
- -20.42%
- YTD
- -22.65%
- 1Y
- -7.03%
- 3Y*
- -31.60%
- 5Y*
- -2.27%
- 10Y*
- -13.21%
FMED
- 1D
- -1.23%
- 1M
- 12.08%
- 6M
- 4.68%
- YTD
- 6.51%
- 1Y
- 21.03%
- 3Y*
- 4.71%
- 5Y*
- —
- 10Y*
- —
VYGR vs. FMED - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
VYGR Voyager Therapeutics, Inc. | -22.65% | -30.69% | -32.82% | -34.93% |
FMED Fidelity Disruptive Medicine ETF | 6.51% | 9.69% | 2.29% | -3.59% |
Correlation
The correlation between VYGR and FMED is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.46 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.50 |
Correlation (All Time) Calculated using the full available price history since Jun 12, 2023 | 0.50 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VYGR vs. FMED — Risk / Return Rank
VYGR
FMED
VYGR vs. FMED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Voyager Therapeutics, Inc. (VYGR) and Fidelity Disruptive Medicine ETF (FMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VYGR | FMED | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.18 | ||
| Sortino ratioReturn per unit of downside risk | -1.37 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 1.19 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | -0.16 | 1.15 | -1.32 |
| Martin ratioReturn relative to average drawdown | -0.31 | 2.51 | -2.82 |
Loading charts...
Drawdowns
VYGR vs. FMED - Drawdown Comparison
The maximum VYGR drawdown since its inception was -92.11%, which is greater than FMED's maximum drawdown of -21.84%. Use the drawdown chart below to compare losses from any high point for VYGR and FMED.
Loading charts...
Drawdown Indicators
| VYGR | FMED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.11% | -21.84% | -70.27% |
Max Drawdown (1Y)Largest decline over 1 year | -42.96% | -18.33% | -24.63% |
Max Drawdown (3Y)Largest decline over 3 years | -74.82% | -21.84% | -52.98% |
Max Drawdown (5Y)Largest decline over 5 years | -80.49% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -92.11% | — | — |
Current DrawdownCurrent decline from peak | -90.29% | -4.30% | -85.99% |
Average DrawdownAverage peak-to-trough decline | -67.08% | -7.00% | -60.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.05% | 8.40% | +14.65% |
Volatility
VYGR vs. FMED - Volatility Comparison
Voyager Therapeutics, Inc. (VYGR) has a higher volatility of 15.02% compared to Fidelity Disruptive Medicine ETF (FMED) at 6.04%. This indicates that VYGR's price experiences larger fluctuations and is considered to be riskier than FMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VYGR | FMED | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.02% | 6.04% | +8.98% |
Volatility (6M)Calculated over the trailing 6-month period | 44.76% | 15.73% | +29.03% |
Volatility (1Y)Calculated over the trailing 1-year period | 64.23% | 19.78% | +44.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 80.91% | 18.68% | +62.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 75.70% | 18.68% | +57.02% |
Dividends
VYGR vs. FMED - Dividend Comparison
Neither VYGR nor FMED has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
FMED Fidelity Disruptive Medicine ETF | 0.00% | 0.00% | 0.46% |
VYGR Voyager Therapeutics, Inc. | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
VYGR and FMED have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VYGR has higher volatility (15.02%) compared to FMED (6.04%). In terms of maximum drawdown, VYGR dropped -92.11% vs FMED's -21.84%.
FMED currently has the higher Sharpe Ratio (1.07 vs -0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VYGR and FMED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer